No products in the cart.
Illumos Secures Angel Funding from Leading Expert in Precision Oncology and Healthcare Entrepreneur

Illumos is thrilled to announce that we have successfully secured angel funding from two distinguished investors: Professor Tony Mok Shu Kam, a globally recognized pioneer in precision oncology, and Dr. David Lai, founder and CEO of WT Health and MedHouse, as well as an active angel investor in the healthcare and biotech sectors.
Professor Mok is celebrated for his groundbreaking research and transformative contributions to biomarker discovery and molecular targeted therapy, particularly in lung cancer. His unparalleled expertise and visionary leadership have not only reshaped the landscape of oncology but have also inspired a new generation of researchers and clinicians. As one of the foremost authorities in the field, his involvement with Illumos underscores our commitment to advancing precision medicine.
Dr. David Lai is a remarkable healthcare entrepreneur with extensive experience in healthcare innovation and investment. His dedication to supporting transformative and impactful technologies in the biotech sector will significantly enhance Illumos’s growth trajectory and further our objectives in clinical application.
This strategic investment will enable Illumos to accelerate our development efforts and expand our capabilities in 3D histology and quantitative biomarker analysis. We are excited about the opportunities that lie ahead as we collaborate with these esteemed investors.
We extend our heartfelt gratitude to Prof. Mok and Dr. Lai for their belief in our vision and their commitment to advancing healthcare.
Illumos 很高興地宣布,我們成功獲得兩位傑出投資者的天使資金:世界知名的精準腫瘤學先驅莫樹錦教授,以及衛冬醫療和 MedHouse的創辦人兼行政總裁黎卓熙醫生,他同時也是活躍於醫療與生物科技賽道的天使投資者。
莫樹錦教授因其在標靶治療和生物標記方面的開創性研究享譽全球,尤其是在肺癌領域的重大貢獻改寫了萬千患者的命運。他的專業知識和遠見不僅重塑了腫瘤學的格局,還啟蒙了新一代科學家和醫生。作為該領域的權威之一,他與Illumos的合作彰顯了我們推進精準醫療的願景。黎卓熙醫生是一位優秀的醫療企業家,擁有豐富的創新醫療和投資經驗。他對推動科研轉化的支持將加速 Illumos 的成長,進一步推進我們佈局臨床應用的目標。
這筆戰略投資將使 Illumos 擴大我們的3D組織學開發規模,提升在生物標記分析方面的能力。我們十分期待與兩位投資者攜手同行,締造更多機會。
讓我們在此衷心感謝莫教授和黎醫生對Illumos願景的肯定及對推進精準醫療的承諾。

